UPDATED: Federal Court Strikes Down Blue Cross Of Michigan's Denial Of Applied Behavior Analysis Therapy To Children With Autism
According to the suit, ABA therapy is a medically and scientifically accepted treatment that enables children with autism to increase communication, motor, and reasoning skills; enhance social functioning; decrease negative behaviors; and lead more independent lives. The U.S. Surgeon General, the National Institutes of Health, the American Academy of Pediatrics, a report commissioned by Medicare and Medicaid, and leading scholars and researchers have all found ABA therapy to be effective in treating autism spectrum disorder. The evidence also shows that denying or delaying treatment can have profound negative consequences to the children. Denial of therapy forever destroys the potential of these children to live full and independent lives.
Despite this evidence, Blue Cross characterized ABA therapy as "experimental" and refused coverage to all children with autism. It was this characterization and denial of coverage for ABA therapy that the federal court in Detroit struck down as illegal.
This ruling comes on the heels of another victory by the same law firms who litigated Berge, et al. v. United States of America, et al., Case No. 10-00373 (D.D.C., Hon. Reggie B. Walton), in which over 20,000 military families successfully sued the Department of Defense and Tricare for their denial of coverage for ABA therapy on similar grounds.
The attorneys for the Plaintiff families in Potter v. Blue Cross are:Gerard V. Mantese, Esq. Brian M. Saxe, Esq.Mantese Honigman Rossmanand Williamson, P.C.1361 E. Big Beaver Road Troy, Michigan 48083248-457-9200 Office248-515-6419 Cell firstname.lastname@example.org email@example.com John J. Conway, Esq. John J. Conway P.C.26622 Woodward Ave., Suite 225 Royal Oak, Michigan 48067313-961-6525 Office313-574-2148 Cell firstname.lastname@example.org SOURCE Mantese Honigman Rossman and Williamson, P.C.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV